The Ministry of Health and Social Services wants careful prescribing and monitoring as public demand for weight loss and metabolic treatments grows.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A GlobeNewswire release forecasts the GLP-1 drug market topping $132 billion within the next decade. Details beyond the headline figure are thin.
The hospital says tirzepatide may help with weight when medically appropriate but calls it no shortcut, urging people to understand the risks first.
Loading…